Biotech
3D-Printed Spinal Repairs Innovated
Advancements in regenerative medicine, including 3D-printed spinal cord repairs, were announced on September 5. The technology aims to restore function in spinal injury patients.
Vaccine Therapy Progress for Brain Tumors
Rapporteret af AI Faktatjekket
Vaccine therapy for malignant glioma is advancing, with calls for expedited approvals to treat this aggressive brain cancer. The approach has potential to save lives and is part of efforts for rare disease treatments. Early results indicate effectiveness without traditional chemo or radiation.
Beyond Meat investor eyes ETHZilla after stock rally
Dimitri Semenikhin, the retail trader who sparked the recent Beyond Meat stock rally, has announced a new investment in ETHZilla Corporation. The company, formerly a biotech firm known as 180 Life Sciences, recently pivoted to a digital asset treasury focused on ethereum. ETHZilla's shares surged following Semenikhin's disclosure, amid a broader trend of companies adopting crypto treasuries in 2025.
Cellular Treatment Outperforms Chemo in Cancer Models
Rapporteret af AI Faktatjekket
A new treatment tested in brain organoids with glioblastoma outperformed chemotherapy and dramatically reduced tumors in mice. Human trials are upcoming. The approach also explores stem cell stimulation and aging cell rejuvenation for broader immunotherapy applications.
Stem Cell EVs Aid Tissue Repair
Rapporteret af AI Faktatjekket
StemDAO is developing therapies using extracellular vesicles from stem cells to address soft tissue injuries, cognitive decline, and aging. Clinical data shows benefits in cognition, skin health, and inflammation reduction. This approach triggers natural regeneration without surgery.